In esophageal and lung cancers, mutp53 suppresses SLC7A11 expression by interacting with the master antioxidant transcription factor NRF2, which promotes the accumulation of ROS and induces ferroptosis [79]. Here, SLC7A11 is linked to lung carcinoma.